OROPHARYNX SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNX SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNX SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weekly combo may offer hope for head and neck cancer patients who can't take standard chemo
Disease control Recruiting nowThis study tests a weekly treatment of two chemotherapy drugs (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in 32 people with advanced head and neck cancer that has spread. It is for patients who cannot take the standard drug 5-fluorouracil. The goal is …
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Blood test may spare throat cancer patients from unnecessary radiation
Disease control Recruiting nowThis study looks at whether a simple blood test can tell which throat cancer patients can safely skip radiation after surgery. About 61 people with HPV-related throat cancer will have their blood tested before and after surgery. If the test is negative after surgery and they are …
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug combo aims to shrink Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink tumors in people with advanced head and neck cancer that has returned or spread after initial treatment. About 40 adults whose cancer worsened after first-line therapy will receive the c…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Blood test could revolutionize Follow-Up for HPV throat cancer patients
Knowledge-focused Recruiting nowThis study looks at whether measuring HPV DNA in the blood can help find throat cancer recurrence earlier in patients with HPV-related oropharyngeal cancer. About 420 participants will be followed after treatment to see if those with undetectable HPV DNA can safely have fewer che…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Blood test may predict throat cancer comeback
Knowledge-focused Recruiting nowThis study follows 220 people with HPV-related throat cancer to see if a simple blood test for HPV DNA and changes in two genes (TRAF3 and CYLD) can predict if the cancer will come back after treatment. Participants will give blood samples and fill out quality-of-life questionnai…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 07, 2026 18:43 UTC